Baxter International Inc (BAX) stock
BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$25.39−0.77 (-2.94%)
Close on Nov 19, 2026Market cap $13.14BP/E –Yield 2.05%
Baxter International free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Baxter International's free cash flow for the twelve months ending Dec 31, 2023 was $1.29B, up 55.2% year over year. For fiscal 2025 it was $332.00M, down 42.1% from the year before. Over ten years it grew -9.1% a year on average. The highest annual figure on record is $2.49B in fiscal 2013.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $332.00M | -42.1% |
| FY2024 | Dec 31, 2024 | $573.00M | -55.7% |
| FY2023 | Dec 31, 2023 | $1.29B | +55.2% |
| FY2022 | Dec 31, 2022 | $834.00M | -45.5% |
| FY2021 | Dec 31, 2021 | $1.53B | +32.1% |
| FY2020 | Dec 31, 2020 | $1.16B | -17.7% |
| FY2019 | Dec 31, 2019 | $1.41B | +3.7% |
| FY2018 | Dec 31, 2018 | $1.36B | +23.7% |
| FY2017 | Dec 31, 2017 | $1.10B | +17.4% |
| FY2016 | Dec 31, 2016 | $935.00M | +8.7% |
| FY2015 | Dec 31, 2015 | $860.00M | -62.4% |
| FY2014 | Dec 31, 2014 | $2.29B | -8.1% |
| FY2013 | Dec 31, 2013 | $2.49B | +28.1% |
| FY2012 | Dec 31, 2012 | $1.95B | +4.7% |
| FY2011 | Dec 31, 2011 | $1.86B | -9.0% |
| FY2010 | Dec 31, 2010 | $2.04B | +7.7% |
| FY2009 | Dec 31, 2009 | $1.90B | +21.4% |
| FY2008 | Dec 31, 2008 | $1.56B | -3.2% |
| FY2007 | Dec 31, 2007 | $1.61B | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $601.00M | +20.2% |
| Q3 FY2023 | Sep 30, 2023 | $191.00M | +48.1% |
| Q2 FY2023 | Jun 30, 2023 | $195.00M | +42.3% |
| Q1 FY2023 | Mar 31, 2023 | $307.00M | +351.5% |
| Q4 FY2022 | Dec 31, 2022 | $500.00M | -2.0% |
| Q3 FY2022 | Sep 30, 2022 | $129.00M | -74.0% |
| Q2 FY2022 | Jun 30, 2022 | $137.00M | -57.1% |
| Q1 FY2022 | Mar 31, 2022 | $68.00M | -67.0% |
| Q4 FY2021 | Dec 31, 2021 | $510.00M | +7.4% |
| Q3 FY2021 | Sep 30, 2021 | $496.00M | +40.1% |
| Q2 FY2021 | Jun 30, 2021 | $319.00M | +38.7% |
| Q1 FY2021 | Mar 31, 2021 | $206.00M | +106.0% |
| Q4 FY2020 | Dec 31, 2020 | $475.00M | -25.5% |
| Q3 FY2020 | Sep 30, 2020 | $354.00M | -33.7% |
| Q2 FY2020 | Jun 30, 2020 | $230.00M | -23.6% |
| Q1 FY2020 | Mar 31, 2020 | $100.00M | – |
| Q4 FY2019 | Dec 31, 2019 | $638.00M | +26.8% |
| Q3 FY2019 | Sep 30, 2019 | $534.00M | +63.8% |
| Q2 FY2019 | Jun 30, 2019 | $301.00M | +19.9% |
| Q1 FY2019 | Mar 31, 2019 | -$65.00M | -123.4% |
| Q4 FY2018 | Dec 31, 2018 | $503.00M | +171.9% |
| Q3 FY2018 | Sep 30, 2018 | $326.00M | -31.2% |
| Q2 FY2018 | Jun 30, 2018 | $251.00M | -32.7% |
| Q1 FY2018 | Mar 31, 2018 | $278.00M | +321.2% |
| Q4 FY2017 | Dec 31, 2017 | $185.00M | -63.9% |
| Q3 FY2017 | Sep 30, 2017 | $474.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $373.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $66.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $513.00M | – |
See a number that looks wrong?